Specific somatoform disorder in the general population

Hans Joergen Grabe; Christian Meyer; Ulfert Hapke; Hans Juergen Rumpf; Harald Juergen Freyberger; Horst Dilling; Ulrich John

doi:10.1176/appi.psy.44.4.304

Specific somatoform disorder in the general population

Hans Joergen Grabe^*, Christian Meyer, Ulfert Hapke, Hans Juergen Rumpf, Harald Juergen Freyberger, Horst Dilling, Ulrich John

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Psychiatrie und Psychotherapie

Universität Greifswald

55 Zitate (Scopus)

Abstract

The authors assessed the validity of the recently proposed diagnosis for specific somatoform disorder in the general population. German versions of the DSM-IV adapted Composite International Diagnostic Interview were administered to a representative sample of 4,075 individuals. Multivariate analyses were used to compare impairment, life satisfaction, and use of health care. A total of 803 of 4,075 subjects (19.7%) with undifferentiated somatization disorder were identified, which included 51 subjects (1.3%) who met criteria for specific somatoform disorder. Subjects with specific somatoform disorder were more impaired, had lower life satisfaction, and had higher use of health care than subjects with undifferentiated somatization disorder only. The proposed diagnosis of specific somatoform disorder demonstrated a high validity independent of comorbid depressive and anxiety disorders.

Originalsprache	Englisch
Zeitschrift	Psychosomatics
Jahrgang	44
Ausgabenummer	4
Seiten (von - bis)	304-311
Seitenumfang	8
ISSN	0033-3182
DOIs	https://doi.org/10.1176/appi.psy.44.4.304
Publikationsstatus	Veröffentlicht - 2003

Fördermittel

This study is part of the German Research Network Analytical Epidemiology of Substance Abuse. Factors related to the use and abuse of psychoactive substances are analyzed by different research groups in the context of several longitudinal studies. Contact persons are Dr. Büringer and Dr. Küfner (IFT Institute for Therapy Research, Munich), Dr. Wittchen (Max-Planck-Institute, Munich), Dr. John (University of Greifswald, Greifswald, Germany), and Dr. Dilling (Medical University of Lübeck, Lübeck, Germany). The German Research Network is funded in the context of the Biological and Psychosocial Factors of Drug Abuse and Dependence by the Federal Ministry of Education , Science, Research, and Technology . Data described in this article are part of Transitions in Alcohol Consumption and Smoking, Part 1: Drug Use in the Adult General Population in a Northern German City and Surrounding Communities, grant 01EB9406 ; principal investigators are Dr. John and Dr. Dilling.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen
SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Dokumente

10.1176/appi.psy.44.4.304

Weitere Links

Link to publication in Scopus

Zitieren

@article{854ef38a115a419cb152ce8f9f5f1234,

title = "Specific somatoform disorder in the general population",

abstract = "The authors assessed the validity of the recently proposed diagnosis for specific somatoform disorder in the general population. German versions of the DSM-IV adapted Composite International Diagnostic Interview were administered to a representative sample of 4,075 individuals. Multivariate analyses were used to compare impairment, life satisfaction, and use of health care. A total of 803 of 4,075 subjects (19.7\%) with undifferentiated somatization disorder were identified, which included 51 subjects (1.3\%) who met criteria for specific somatoform disorder. Subjects with specific somatoform disorder were more impaired, had lower life satisfaction, and had higher use of health care than subjects with undifferentiated somatization disorder only. The proposed diagnosis of specific somatoform disorder demonstrated a high validity independent of comorbid depressive and anxiety disorders.",

author = "Grabe, \{Hans Joergen\} and Christian Meyer and Ulfert Hapke and Rumpf, \{Hans Juergen\} and Freyberger, \{Harald Juergen\} and Horst Dilling and Ulrich John",

note = "Funding Information: This study is part of the German Research Network Analytical Epidemiology of Substance Abuse. Factors related to the use and abuse of psychoactive substances are analyzed by different research groups in the context of several longitudinal studies. Contact persons are Dr. B{\"u}ringer and Dr. K{\"u}fner (IFT Institute for Therapy Research, Munich), Dr. Wittchen (Max-Planck-Institute, Munich), Dr. John (University of Greifswald, Greifswald, Germany), and Dr. Dilling (Medical University of L{\"u}beck, L{\"u}beck, Germany). The German Research Network is funded in the context of the Biological and Psychosocial Factors of Drug Abuse and Dependence by the Federal Ministry of Education , Science, Research, and Technology . Data described in this article are part of Transitions in Alcohol Consumption and Smoking, Part 1: Drug Use in the Adult General Population in a Northern German City and Surrounding Communities, grant 01EB9406 ; principal investigators are Dr. John and Dr. Dilling. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",

year = "2003",

doi = "10.1176/appi.psy.44.4.304",

language = "English",

volume = "44",

pages = "304--311",

journal = "Psychosomatics",

issn = "0033-3182",

publisher = "American Psychiatric Publishing Inc.",

number = "4",

}

TY - JOUR

T1 - Specific somatoform disorder in the general population

AU - Grabe, Hans Joergen

AU - Meyer, Christian

AU - Hapke, Ulfert

AU - Rumpf, Hans Juergen

AU - Freyberger, Harald Juergen

AU - Dilling, Horst

AU - John, Ulrich

N1 - Funding Information: This study is part of the German Research Network Analytical Epidemiology of Substance Abuse. Factors related to the use and abuse of psychoactive substances are analyzed by different research groups in the context of several longitudinal studies. Contact persons are Dr. Büringer and Dr. Küfner (IFT Institute for Therapy Research, Munich), Dr. Wittchen (Max-Planck-Institute, Munich), Dr. John (University of Greifswald, Greifswald, Germany), and Dr. Dilling (Medical University of Lübeck, Lübeck, Germany). The German Research Network is funded in the context of the Biological and Psychosocial Factors of Drug Abuse and Dependence by the Federal Ministry of Education , Science, Research, and Technology . Data described in this article are part of Transitions in Alcohol Consumption and Smoking, Part 1: Drug Use in the Adult General Population in a Northern German City and Surrounding Communities, grant 01EB9406 ; principal investigators are Dr. John and Dr. Dilling. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.

PY - 2003

Y1 - 2003

N2 - The authors assessed the validity of the recently proposed diagnosis for specific somatoform disorder in the general population. German versions of the DSM-IV adapted Composite International Diagnostic Interview were administered to a representative sample of 4,075 individuals. Multivariate analyses were used to compare impairment, life satisfaction, and use of health care. A total of 803 of 4,075 subjects (19.7%) with undifferentiated somatization disorder were identified, which included 51 subjects (1.3%) who met criteria for specific somatoform disorder. Subjects with specific somatoform disorder were more impaired, had lower life satisfaction, and had higher use of health care than subjects with undifferentiated somatization disorder only. The proposed diagnosis of specific somatoform disorder demonstrated a high validity independent of comorbid depressive and anxiety disorders.

AB - The authors assessed the validity of the recently proposed diagnosis for specific somatoform disorder in the general population. German versions of the DSM-IV adapted Composite International Diagnostic Interview were administered to a representative sample of 4,075 individuals. Multivariate analyses were used to compare impairment, life satisfaction, and use of health care. A total of 803 of 4,075 subjects (19.7%) with undifferentiated somatization disorder were identified, which included 51 subjects (1.3%) who met criteria for specific somatoform disorder. Subjects with specific somatoform disorder were more impaired, had lower life satisfaction, and had higher use of health care than subjects with undifferentiated somatization disorder only. The proposed diagnosis of specific somatoform disorder demonstrated a high validity independent of comorbid depressive and anxiety disorders.

UR - https://www.scopus.com/pages/publications/0037867077

U2 - 10.1176/appi.psy.44.4.304

DO - 10.1176/appi.psy.44.4.304

M3 - Journal articles

C2 - 12832596

AN - SCOPUS:0037867077

SN - 0033-3182

VL - 44

SP - 304

EP - 311

JO - Psychosomatics

JF - Psychosomatics

IS - 4

ER -

Specific somatoform disorder in the general population

Abstract

Fördermittel

UN SDGs

Strategische Forschungsbereiche und Zentren

Dokumente

Weitere Links

Fingerprint

Zitieren